The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
Open accessAbstract
Alzheimer disease (AD) is the most common cause of dementia in people over 60 years old. The molecular and cellular alterations that trigger this disease are still diffuse, one of the reasons for the delay in finding an effective treatment. In the search for new targets to search for novel therapeutic avenues, clinical studies in patients who used anti-inflammatory drugs indicating a lower incidence of AD have been of value to support the neuroinflammatory hypothesis of the neurodegenerative processes and the role of innate immunity in this disease. Neuroinflammation appears to occur as a consequence of a series of damage signals, including trauma, infection, oxidative agents, redox iron, oligomers of τ and β-amyloid, etc. In this context, our theory of Neuroimmunomodulation focus on the link between neuronal damage and brain inflammatory process, mediated by the progressive activation of astrocytes and microglial cells with the consequent overproduction of proinflammatory agents. Here, we discuss about the role of microglial and astrocytic cells, the principal agents in neuroinflammation process, in the development of neurodegenerative diseases such as AD. In this context, we also evaluated the potential relevance of natural anti-inflammatory components, which include curcumin and the novel Andean Compound, as agents for AD prevention and as a coadjuvant for AD treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it remains unclear whether microglial activation is a primary triggering mechanism or merely a consequence of protein aggregate accumulation [60]”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Alzheimer’s disease, neuroinflammation is primarily thought to be a consequence of a series of damage signals including trauma, oxidation, oligomers of Aβ and tau, and more [67].”
From Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients (2024) · cites this paper as [67]
Experimental — accuracy not yet measuredIn the citing paper
“Pro-inflammatory cytokines and chemokines secreted into the immediate neurological environment accelerate neuronal injury and eventually neuron death (Aktas et al., 2007; Heckmann et al., 2018; Morales et al.,2014).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Morales et al.,2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,139
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis
Christopherson, K. S., Ullian, E. M., Stokes, C. C. A., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2004.12.020 · Cited by 1,688
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Even in mice, NSAIDs directly affect the development of amyloid in the brain, reducing Aβ-42 peptide levels (Weggen et al., 2001).”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- Powell, 1999, Dissection of astrocyte-mediated cues in neuronal guidance and process extension, Glia, 26, 73, 10.1002/(sici)1098-1136(199903)26:173::aid-glia83.0.co;2-s · DOI
Cited by
Sorted by citations
Items 201–300 of 504
Zeng, K., Yu, Q., Liao, L., Song, F., Lv, H., Jiang, Y., & Tu, P. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25084 · Cited by 36
de Andrade, A. M., Fernandes, M. D. C., de Fraga, L. S., Porawski, M., Giovenardi, M., & Guedes, R. P. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0080-7 · Cited by 39
Vargas-Restrepo, F., Sabogal-Guáqueta, A. M., & Cardona‐Gómez, G. P. (2017) · Biomédica · doi:10.7705/biomedica.v38i0.3761 · Cited by 36
Elfakhri, K. H., Abdallah, I. M., Brannen, A. D., & Kaddoumi, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.020 · Cited by 36
Liu, W., Huang, S., Li, Y., Zhang, K., & Zheng, X. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.1516 · Cited by 36
Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
Permpoonputtana, K., Tangweerasing, P., Mukda, S., Boontem, P., Nopparat, C., & Govitrapong, P. (2018) · EXCLI journal · doi:10.17179/excli2017-654 · Cited by 35
Sutinen, E. M., Korolainen, M. A., Häyrinen, J., Alafuzoff, I., Petratos, S., Salminen, A., Soininen, H., Pirttilä, T., & Ojala, J. O. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00214 · Cited by 34
Nebrisi, E. E., Bağdaş, D., Toma, W. B., Alsamri, H., Brodzik, A., Alkhlaif, Y., Yang, K. S., Howarth, F. C., Damaj, M. I., & Öz, M. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245068 · Cited by 34
Farag, A. K., Hassan, A. H. E., Jeong, H., Kwon, Y., Choi, J. G., Oh, M. S., Park, K. D., Kim, Y. K., & Roh, E. J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.057 · Cited by 34
Long Non-Coding RNAs, Extracellular Vesicles and Inflammation in Alzheimer’s Disease
Canseco-Rodríguez, A., Masola, V., Aliperti, V., Meseguer-Beltrán, M., Donizetti, A., & Sánchez‐Pérez, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113171 · Cited by 34
Qu, C. F., Xu, Q., Yang, W., Zhong, M., Yuan, Q., Xian, Y., & Lin, Z. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.07.014 · Cited by 35
Alkaloids as Potential Multi-Target Drugs to Treat Alzheimer's Disease
Lima, J. A., & Hamerski, L. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64183-0.00008-7 · Cited by 34
Liao, Q., Li, Q., Zhao, Y., Jiang, P. H., Yan, Y., Sun, H., Liu, W., Feng, F., & Qu, W. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103844 · Cited by 33
Wang, H., Yang, T., Sun, J., Zhang, S., & Liu, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16689 · Cited by 31
Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit
Alam, Q., & Krishnamurthy, S. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100091 · Cited by 34
Sideris, E., Kioulaphides, S., Wilson, K. L., Yu, A., Chen, J., Carmichael, S. T., & Segura, T. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200048 · Cited by 30
Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs
Liang, Y., & Wang, L. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115656 · Cited by 36
Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
Fakorede, S., Lateef, O. M., Garuba, W. A., Akosile, P. O., Okon, D. A., & Aborode, A. T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251341870 · Cited by 40
Rodrigues, M. J., Ślusarczyk, S., Pecio, Ł., Matkowski, A., Salmas, R. E., Durdağı, S., Pereira, C. G., Varela, J. C. S., Barreira, L. A., & Custódio, L. M. B. (2017) · Industrial Crops and Products · doi:10.1016/j.indcrop.2017.10.046 · Cited by 32
Go, J., Ha, T. K. Q., Seo, J. Y., Park, T., Ryu, Y., Park, H., Noh, J., Kim, Y., Hwang, J. H., Choi, D., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.002 · Cited by 32
Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains
Biase, D. D., Piegari, G., Prisco, F., Cimmino, I., Pirozzi, C., Raso, G. M., Oriente, F., Grieco, E., Papparella, S., & Paciello, O. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29426 · Cited by 32
H2S-based fluorescent imaging for pathophysiological processes
Jia, T.-T., Zhang, Y., Hou, J., Niu, H., & Wang, S. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1126309 · Cited by 32
Lee, B. H., Nam, T. G., Park, W. J., Kang, H. G., Heo, H. J., Chung, D. K., Kim, G. H., & Kim, D. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0093-0 · Cited by 32
Qin, J., Zhang, X., Wang, Z., Li, J., Zhang, Z., Gao, L., Ren, H., Qian, M., & Du, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0347-4 · Cited by 32
Kurucz, A., Bombicz, M., Kiss, R., Priksz, D., Varga, B., Hortobágyi, T., Trencsényi, G., Szabó, R., Pósa, A., Gesztelyi, R., et al. (2018) · BioMed Research International · doi:10.1155/2018/7212861 · Cited by 32
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1051 · Cited by 32
Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, A. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577561 · Cited by 31
Neuroprotective Role of Polyphenols in Treatment of Neurological Disorders: A Review
Maqbool, M., & Zehravi, M. (2021) · Interventional Pain Medicine and Neuromodulation · doi:10.5812/ipmn.117170 · Cited by 34
Kalra, J., Kumar, P., Majeed, A. B. A., & Prakash, A. K. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.04.002 · Cited by 31
Skaper, S. D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.08.004 · Cited by 31
Natunen, T., Takalo, M., Kemppainen, S., Leskelä, S., Marttinen, M., Kurkinen, K. M. A., Pursiheimo, J., Sarajärvi, T., Viswanathan, J., Gabbouj, S., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.005 · Cited by 31
Small Molecule Natural Products and Alzheimer’s Disease
Wu, X., Cai, H., Pan, L., Cui, G., Qin, F., Li, Y., & Cai, Z. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190201153257 · Cited by 29
Cheng, Y., Ding, Y., Bian, G., Chen, L.-W., Yao, X.-Y., Lin, Y.-B., Wang, Z., & Chen, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.023 · Cited by 31
Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
González, A., Singh, S. K., Churruca, M., & Maccioni, R. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084192 · Cited by 30
Self-citationRole of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease
Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 31
Bridging the gap: glucose transporters, Alzheimer’s, and future therapeutic prospects
Albaik, M., Saleh, D. S., Kauther, D., Mohammed, H., Alfarra, S., Alghamdi, A., Ghaboura, N., & Sindi, I. A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1344039 · Cited by 34
Clementino, A., Marchi, C., Pozzoli, M., Bernini, F., Zimetti, F., & Sonvico, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716380 · Cited by 31
Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation
Farooq, R. K., Alamoudi, W., Alhibshi, A., Rehman, S., Sharma, A. R., & Abdulla, F. A. (2022) · Microorganisms · doi:10.3390/microorganisms10040705 · Cited by 31
Jayasena, T., Poljak, A., Braidy, N., Smythe, G., Raftery, M., Hill, M., Brodaty, H., Trollor, J., Kochan, N., & Sachdev, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116092 · Cited by 30
Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice
Park, J.-C., Ma, J., Jeon, W. K., & Han, J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1033-0 · Cited by 29
Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases
Edison, P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.017 · Cited by 27
Chen, H., Dong, B., Shi, Y., Yu, Y., & Xie, K. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.05.003 · Cited by 28
Yang, Y., Seok, M., Kim, Y. E., Choi, Y., Song, J., Sulistio, Y. A., Kim, S., Chang, M., Oh, S., Nam, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01693-6 · Cited by 30
Herzer, S., Hagan, C., von Gerichten, J., Dieterle, V., Munteanu, B., Sandhoff, R., Hopf, C., & Nordström, V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00206 · Cited by 27
He, Y., Cong, L., Liang, S.-L., Ma, X., Tian, J.-N., Li, H., & Wu, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1056312 · Cited by 28
Ferroptosis: a potential therapeutic target for Alzheimer’s disease
Yang, L., & Nao, J. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0121 · Cited by 28
Leite, M. R., Cechella, J. L., Pinton, S., Nogueira, C. W., & Zeni, G. R. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.006 · Cited by 27
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 34
Self-citationAlzheimer’s disease: from early pathogenesis to novel therapeutic approaches
Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21
Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease
Neha, N., & Parvez, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101815 · Cited by 28
Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease
Lin, L., Jhao, Y.-T., Chiu, C., Sun, L.-H., Chou, T.-K., Shiue, C., Cheng, C., & Ma, K. (2022) · Pharmaceuticals · doi:10.3390/ph15020109 · Cited by 27
Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia
Arenas, Y. M., Martinez‐García, M., Llansola, M., & Felipo, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911770 · Cited by 26
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease
Kabir, E. R., Chowdhury, N. M., Yasmin, H., Kabir, M. T., Akter, R., Perveen, A., Ashraf, G. M., Akter, S., Rahman, M. H., & Sweilam, S. H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221010113812 · Cited by 26
The Role of PGRN in Alzheimer’s Disease
Jing, H., Tan, M., Yu, J., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9358-0 · Cited by 25
Alzheimer's Disease and Its Potential Alternative Therapeutics.
Kisby, B. R., Jarrell, J. T., Me, A., Ds, C., Er, R., Cm, C., Rogers, J. T., & Huang, X. (2019) · PubMed · doi:10.4172/2161-0460.1000477 · Cited by 25
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
Kopp, K. O., Greer, M. E., Glotfelty, E. J., Hsueh, S., Tweedie, D., Kim, D. S., Reale, M., Vargesson, N., & Greig, N. H. (2023) · Biomolecules · doi:10.3390/biom13050747 · Cited by 26
Association of CD33 and MS4A cluster variants with Alzheimer’s disease in East Asian populations
Mao, Y., Guo, Z., Pu, J., Chen, Y., & Zhang, B. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.007 · Cited by 25
Ni, W., Niu, Y., Cao, S., Fan, C., Fan, J., Zhu, L., & Wang, X. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03160-1 · Cited by 24
Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review
Ahmad, S. S., Khalid, M., Kamal, M. A., & Younis, K. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210215122333 · Cited by 26
Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights
Islam, M. R., Akash, S., Islam, M. M., Sarkar, N., Kumer, A., Chakraborty, S., Dhama, K., Al‐Shaeri, M., Anwar, Y., Wilairatana, P., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148886 · Cited by 27
Zeng, Q., Man, R., Luo, Y., Zeng, L., Zhong, Y., Lu, B.-X., & Wang, X. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0966-1 · Cited by 24
Current viral-mediated gene transfer research for treatment of Alzheimer’s disease
Sasmita, A. O. (2018) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2018.1523521 · Cited by 26
Yang, T., Sun, J., Wei, B., & Liu, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29241 · Cited by 23
Xia, Z., Peng, W., Cheng, S., Zhong, B., Sheng, C., Zhang, C., Gong, W., Cheng, S., Li, J., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17337 · Cited by 23
Sepúlveda-Lara, A., Sepúlveda, P., & Marzuca-Nassr, G. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137084 · Cited by 24
Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
Kakkar, A., Singh, H., Singh, B. K., Kumar, A., Mishra, A. K., & Chopra, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374353 · Cited by 26
Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis
O’Connor, A. T., & Clark, M. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2557-0 · Cited by 22
Cranston, A., Wysocka, A., Steczkowska, M., Zadrożny, M., Pałasz, E., Harrington, C. R., Theuring, F., Wischik, C. M., Riedel, G., & Niewiadomska, G. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa033 · Cited by 22
Huang, S., Liu, W., Li, Y., Zhang, K., Zheng, X., Wu, H., & Tang, G. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00578 · Cited by 23
Ge, X., Wang, Y., Yu, S., Cao, X., Chen, Y., Cheng, Q., & Ding, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716177 · Cited by 22
Rahman, M. M., Mim, S. A., Tumpa, M. A. A., Sarker, M. T., Ahmed, M., Alghamdi, B. S. A., Hafeez, A., Alexiou, A. T., Perveen, A., & Ashraf, G. M. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155962 · Cited by 24
Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease
Pandey, S. N., Singh, G., Semwal, B. C., Gupta, G., Alharbi, K. S., Almalki, W. H., Albratty, M., Najmi, A., & Meraya, A. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14426 · Cited by 23
Chen, Y., Qi, Z., Qiao, B., Lv, Z., Hao, Y., & Li, H. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576978 · Cited by 22
Chavoshinezhad, S., Kouchesfahani, H. M., Salehi, M. S., Pandamooz, S., Ahmadiani, A., & Dargahi, L. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.06.015 · Cited by 23
Qasem, H., AL-Ayadhi, L. Y., Dera, H. S. A., & El-Ansary, A. K. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0391-4 · Cited by 21
Naturally Inspired Pyrimidines Analogues for Alzheimer’s Disease
Singh, S., Dhanawat, M., Gupta, S., Kumar, D., Kakkar, S., Nair, A. B., Verma, I., & Sharma, P. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201111110136 · Cited by 21
Yuan, Q., Wu, Y., Wang, G., Zhou, X., Dong, X., Lou, Z., Li, S., & Wang, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01031-3 · Cited by 21
Prevention of Alzheimer's Disease: A Global Challenge for Next Generation Neuroscientists
Rodríguez‐Gómez, O., Palacio-Lacambra, M.-E., Palasí, A., Ruiz, A., & Boada, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141479 · Cited by 21
Grifasi, I. R., Evans, W. A., Rexha, A. D., Sako, L. W., & Marshall, S. A. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.018 · Cited by 21
Correlative Microscopy to Localize and Characterize Iron Deposition in Alzheimer’s Disease
Madsen, S. J., DiGiacomo, P. S., Zeng, Y., Goubran, M., Chen, Y., Rutt, B. K., Born, D. E., Vogel, H. S., Sinclair, R., & Zeineh, M. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200234 · Cited by 20
Shen, J., Wang, H., Huang, H., Li, H., Li, C., Yan, C., Yu, T., Guo, H., Hu, K., Du, Y., et al. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461867 · Cited by 20
Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer’s Disease
Adeyemı, O. S., Awakan, O. J., Afolabi, B., Rotimi, D. E., Oluwayemi, E. T., Otuechere, C. A., Ibraheem, O., Elebiyo, T. C., Alejolowo, O. O., & Arowolo, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5522981 · Cited by 20
Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_2 · Cited by 21
MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
Garello, F., Pagoto, A., Arena, F., Buffo, A., Blasi, F., Alberti, D., & Terreno, E. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.002 · Cited by 21
Phα1β Spider Toxin Reverses Glial Structural Plasticity Upon Peripheral Inflammation
Tenza‐Ferrer, H., Magno, L. A. V., Romano‐Silva, M. A., da Silva, J. F., & Gomez, M. V. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00306 · Cited by 19
Wang, Y., Gao, Y., Li, X., Sun, X., Wang, Z., Wang, H., Nie, R., Yu, W., & Zhou, Y. (2020) · BioMed Research International · doi:10.1155/2020/4616308 · Cited by 21
Machado, S. M. T., Castro, R. A. E., Maria, T. M. R., Canotilho, J., & Eusébio, M. E. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.012 · Cited by 20
Modulatory Effects of Dietary Amino Acids on Neurodegenerative Diseases
Rajagopal, S., Sangam, S. R., Singh, S., & Rao, J. V. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_22 · Cited by 19
Multicellular hypothesis for the pathogenesis of Alzheimer's disease
Goetzl, E. J., & Miller, B. L. (2017) · The FASEB Journal · doi:10.1096/fj.201601221r · Cited by 20
Neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders
Leite, J. A., Orellana, A. M., Kinoshita, P. F., de Mello, N. P., Scavone, C., & Kawamoto, E. M. (2017) · InTech eBooks · doi:10.5772/intechopen.69343 · Cited by 20
Andrade, V., Cortés, N., Pastor, G., González, A., Ramos-Escobar, N., Pastene, E., Rojo, L. E., & Maccioni, R. B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200067 · Cited by 19
Self-citationA review of autophagy mechanism of statins in the potential therapy of Alzheimer’s disease
Liu, L., Dai, W.-Z., Zhu, X., & Ma, T. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102046 · Cited by 20
Qin, N., Li, S.-G., Yang, X., Gong, C., Zhang, X., Wang, J., Li, D., Guo, Y., Li, Z., & Hua, H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.058 · Cited by 19
Brain interleukins and Alzheimer’s disease
Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 20
Dong, X., & Qu, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877872 · Cited by 18
Cheon, J., Kwon, S.-Y., & Kim, M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14432 · Cited by 20
Clinical benefits of green tea consumption for cognitive dysfunction
Ide, K., & Yamada, H. (2015) · PharmaNutrition · doi:10.1016/j.phanu.2015.07.001 · Cited by 19
Late Passage Cultivation Induces Aged Astrocyte Phenotypes in Rat Primary Cultured Cells
Bang, M., Gonzales, E. L., Shin, C. Y., & Kwon, K. J. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.175 · Cited by 19
Cheng, B. H., Lin, Y., Kuang, M., Fang, S., Gu, Q., Xu, J., & Wang, L. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12581 · Cited by 18
Schrecengost, R. S., Green, C. L., Zhuang, Y., Keller, S. N., Smith, R. A., Maines, L. W., & Smith, C. D. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245738 · Cited by 18
Metadata
- Authors
- Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B.
- Affiliations
- University of Chile (CL)
- Corresponding author
- Maccioni, Ricardo B.
- ORCID
- Maccioni, Ricardo B.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-04-22
- Volume
- 8
- Pages
- 112-112
- ISSN
- 1662-5102 (ISSN-L)
- PMC
- PMC4001039
- OpenAlex
- W2109984042
- Cited by
- 490
- References
- 85
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 43 · 2023: 38 · 2022: 45 · 2021: 40 · 2020: 50 · 2019: 48 · 2018: 45 · 2017: 50 · 2016: 25 · 2015: 50 · 2014: 14
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Corporación de Fomento de la Producción
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, neuroimmunomodulation, microglia, astrocytes, innate immunity, anti-inflammatory agents, tau oligomers, amyloid-beta, oxidative stress, iron, curcumin, neurodegeneration, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
